Goldline Pharmaceutical SME IPO Allotment Status
The Goldline Pharmaceutical SME IPO closed on 14 May 2026. Allotment will be finalised on 15 May 2026. Refunds for unsuccessful applicants will be initiated on 16 May 2026. Shares will be credited to demat accounts on 16 May 2026. The stock lists on NSE and BSE on 19 May 2026.
Issue Price
Rs 43.00
Allotment Date
15 May 2026
Refund Date
16 May 2026
Share Credit Date
16 May 2026
Listing Date
19 May 2026
Registrar
Bigshare Services
GMP Today
Rs 15.00 (34.88%)
Est. Listing Price
Rs 58.00
Est. Profit / Lot
Rs 90,000.00
Goldline Pharmaceutical SME IPO Allotment Chances
The IPO closed with an overall subscription of 840.81x. Here is what that means for each category.
NII Category: NII subscription was 1,662.39x based on shares applied. NII allotment is proportional, not by lottery. At this oversubscription level, NII applicants will receive a very small fraction of the shares they applied for.
QIB Category: QIB subscription came in at 180.22x. QIB allotment is handled by the book running lead managers and is not accessible to retail investors.
Check the Goldline Pharmaceutical SME IPO Subscription Status for the full category-wise breakdown.
How to Check Goldline Pharmaceutical SME IPO Allotment Status
Allotment status will be available from 15 May 2026. There are four ways to check.
Option 1: Via IPOwiz App
- Download the IPOwiz App from the Play Store
- Add the PAN numbers you want to check in the PAN section
- Go to the Allotted section and select Goldline Pharmaceutical SME
- View the allotment status for the saved PAN numbers
Option 2: Via Bigshare Services Website
- Visit the Bigshare Services Allotment Page
- Select Goldline Pharmaceutical SME from the drop-down menu
- Enter your PAN number, application number, or demat account details
- Click Search to view your allotment status
Bigshare Services is the official registrar for this IPO. This is the most direct method to check your result.
Option 3: Via BSE Website
- Go to the BSE IPO allotment page
- Select Goldline Pharmaceutical SME from the list
- Enter your PAN number, application number, or demat account details
- Click Search to check your status
Option 4: Via Demat Account
Log in to your demat or trading account from 16 May 2026 onwards. If shares have been credited, your allotment was successful. Share credit is expected on 16 May 2026.
What Happens After Allotment?
Once allotment is finalised on 15 May 2026, the process moves as follows.
If you are allotted shares: Shares will be credited to your demat account on 16 May 2026. You can hold or sell on listing day, 19 May 2026. Based on current GMP of Rs 15.00, the estimated listing price is Rs 58.00 per share.
If you are not allotted shares: Your blocked amount (ASBA) will be unblocked and refunded on 16 May 2026. The refund goes back to the bank account linked to your application. UPI-based applications are unblocked automatically. ASBA applications through net banking are unblocked by your bank.
On listing day: The stock lists on NSE and BSE on 19 May 2026. You can sell your allotted shares from the moment trading begins.
For listing day updates, follow the IPOwiz Telegram Channel.
Goldline Pharmaceutical SME IPO Registrar Details
The registrar for this IPO is Bigshare Services. For allotment queries or discrepancies, you can contact them directly.
| Field | Value |
|---|---|
| Registrar | Bigshare Services Private Limited |
| Website | bigshareonline.com |
| Allotment Check | Bigshare Services IPO Allotment Page |
| ipo@bigshareonline.com | |
| Phone | 022-6263 8200 (toll free) |
Goldline Pharmaceutical SME IPO Details
| Field | Value |
|---|---|
| Price Band | ₹41.0 - ₹43.0 |
| Issue Size | ₹11.61 Cr |
| Lot Size | 3000 shares |
| Minimum Investment | Rs 2,58,000.00 |
| IPO Type | BSE SME |
| Open Date | 12 May 2026 |
| Close Date | 14 May 2026 |
| Allotment Date | 15 May 2026 |
| Listing Date | 19 May 2026 |
| Overall Subscription | 840.81x |
Goldline Pharmaceutical SME IPO full details including financials, valuation, and review.
About Goldline Pharmaceutical SME
Goldline Pharmaceutical Limited, incorporated in 2021, is a pharmaceutical marketing company that operates under an asset-light business model. The company markets a wide range of pharmaceutical formulations under its proprietary brand 'Goldline', across five specialized divisions: Pharma (General), Cardinal (Specialty), Aayushman (Pediatric), InLife (Critical Care), and Wellness (Supportive Care). Instead of in-house manufacturing, Goldline partners with 15 third-party manufacturers and utilizes a network of 7 distributors to supply products to retailers and hospitals across Maharashtra, Tamil Nadu, Rajasthan, and other states.
Goldline Pharmaceutical SME IPO Subscription Status
Category-wise subscription and allotment chances
Goldline Pharmaceutical SME IPO GMP Today
Live GMP, listing price estimate, listing gain
Goldline Pharmaceutical SME IPO Details
Financials, peers, strengths, and review
IPOwiz Allotment Checker
Check allotment for multiple PANs at once
Goldline Pharmaceutical SME IPO Listing Price
Listing day GMP vs actual listing price and gain
Goldline Pharmaceutical SME IPO Allotment FAQs
When will the Goldline Pharmaceutical SME IPO allotment be finalised?
Allotment will be finalised on 15 May 2026. Results will be available on the Bigshare Services website, BSE website, and the IPOwiz App from that date.
What are the allotment chances for retail investors?
Retail allotment chances depend on final oversubscription. Allotment is by lottery when retail subscription exceeds 1x.
When will shares be credited to demat accounts?
Shares will be credited to demat accounts on 16 May 2026, one day before listing.
When is the Goldline Pharmaceutical SME listing date?
The stock is scheduled to list on NSE and BSE on 19 May 2026.
When will refunds be processed?
Refunds for unsuccessful applicants will be initiated on 16 May 2026. UPI-based ASBA amounts are unblocked automatically. Net banking ASBA amounts are unblocked by your bank.
Can I sell shares on listing day?
Yes. Allotted shares can be sold from the moment trading begins on 19 May 2026.
What should I do if I am not allotted shares?
Your blocked amount will be refunded on 16 May 2026. No action is required from your side. The refund goes back to the bank account linked to your application.
How is allotment done in an IPO?
In the retail category, allotment is done by lottery when the IPO is oversubscribed. SEBI mandates a minimum of one lot per successful applicant. In the NII category, allotment is proportional. In the QIB category, allotment is at the discretion of the book running lead managers.
Can I check allotment status using my PAN number?
Yes. PAN number is the easiest way to check allotment status on the Bigshare Services website, BSE website, or IPOwiz App.
Who should I contact for allotment queries?
Contact the registrar, Bigshare Services, at ipo@bigshareonline.com or call 022-6263 8200 (toll free). You can also raise a query through the BSE SCORES platform.
What is the expected listing price of Goldline Pharmaceutical SME?
Based on the current GMP of Rs 15.00, the estimated listing price is Rs 58.00 per share. This is an unofficial estimate based on grey market activity. The actual listing price will be confirmed on 19 May 2026.
Check your allotment status from 15 May 2026 on the IPOwiz Allotment Checker. For listing day updates on 19 May 2026, follow the IPOwiz Telegram Channel or download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Allotment guide verified before publish.